Accessibility Menu
LifeStance Health Group logo

LifeStance Health Group(NASDAQ) LFST

Market Cap$4.22BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2021)-50%
5 Year-52%
1 Year+170%
1 Month+9%
$11.24
+3.31%
+0.36Today
LifeStance Health Group last closing stock price
MetricPriceDate
Last closeUSD 11.242026-07-28
LifeStance Health Group stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-1.83%USD 11.452026-07-21
1 month+9.34%USD 10.282026-06-26
3 month+51.28%USD 7.432026-04-29
Year to date+59.66%USD 7.042025-12-31
1 year+169.54%USD 4.172025-07-28
3 year+23.11%USD 9.132023-07-28
5 year-52.09%USD 23.462021-07-29
Since inception-50.32%USD 21.902021-06-10

LifeStance Health Group Financials at a Glance

Market Cap

$4.22BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$1.49B

Net Income (TTM)

$23.20M

EPS (TTM)

$0.06

P/E Ratio

183.78

Dividend

$0.00

Beta (Volatility)

1.36 (Average)

Price

$11.24

Volume

71,172

Open

$10.91

Previous Close

$11.24

Daily Range

$10.69 - $11.25

52-Week Range

$3.74 - $11.76

Estimated Earnings Date

Aug 6, 2026

LFST: Motley Fool Moneyball Superscore

59

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About LifeStance Health Group

LifeStance makes it easier for people to get mental health care. Patients can see therapists or doctors either online or at local clinics. The company connects these services with insurance to keep treatments affordable.

Mental Health Services for Everyone

  • Psychiatric Care: Medical evaluations and medication treatments for complex conditions; part of the 90% of revenue from commercial insurance.
  • Talk Therapy: Individual, family, and group sessions for conditions like anxiety, depression, and trauma.
  • Clinical Testing: Specialized assessments to diagnose psychological and neuropsychological conditions in children and adults.
  • Virtual Care: Digital tools for video visits, online scheduling, and secure messaging with clinicians.

Expanding the Digital Reach

  • Reached 33 states with a workforce of 8,040 licensed clinicians by the end of 2025.
  • Launched a strategic re-focus in 2023 to close underoccupied offices and lower real estate costs.
  • Shifted the business model to favor virtual care visits to match changing patient preferences.

What Makes the Model Unique

LifeStance operates a hybrid system where patients can move between video calls and in-person office visits. This flexibility helps patients stay in treatment even when their daily schedules or locations change.

Key Financial Wins in 2025

  • Revenue reached $382.2 million in Q4 2025, up 17.4% year-over-year.
  • Operating income rose to $18.4 million in Q4 2025, up 1642.1% from the previous year.
  • Net income hit $11.7 million in Q4 2025, up 264.1% from Q4 2024.
  • Free cash flow reached $82.8 million in Q4 2025, a 47.8% increase from the prior year.

Bottom Line

LifeStance has evolved from a network of physical clinics into a national, tech-driven health platform. Its move toward virtual care has improved efficiency and turned previous losses into recent profitability.

AI Generated • Apr 26, 2026

Industry

Healthcare Providers and Services

Employees

10,961

CEO

David Patrick Bourdon, MBA

Headquarters

Scottsdale, AZ 85251, US

LFST Financials

Key Financial Metrics (TTM)

Gross Margin

32.60%

Operating Margin

3.00%

Net Income Margin

1.55%

Return on Equity

1.56%

Return on Capital

1.41%

Return on Assets

1.08%

Earnings Yield

0.54%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$4.22BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

387.83M

Volume

71.17K

Avg. Volume

4.89M

Financials (TTM)

Gross Profit

$487.24M

Operating Income

$44.83M

EBITDA

$98.29M

Operating Cash Flow

$182.35M

Capital Expenditure

-$3.60M

Free Cash Flow

$178.75M

Cash & ST Invst.

$194.80M

Total Debt

$196.19M

LifeStance Health Group Performance Analysis

LifeStance Health Group annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 859,542,00028.8%
20232023-12-31USD 1,055,665,00022.8%
20242024-12-31USD 1,250,970,00018.5%
20252025-12-31USD 1,424,285,00013.9%
LifeStance Health Group sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-303.7%
Q32025-09-305.4%
Q42025-12-315.1%
Q12026-03-315.6%
LifeStance Health Group annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD -0.61-42.2%
20232023-12-31USD -0.51-16.5%
20242024-12-31USD -0.15-70.1%
20252025-12-31USD 0.02N/A
LifeStance Health Group sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-30N/A
Q32025-09-30100.0%
Q42025-12-31N/A
Q12026-03-3134.7%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$403.48M

+21.2%

Gross Profit

$135.93M

+23.8%

Gross Margin

33.69%

N/A

Market Cap

$4.22BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$505.41K

N/A

Employees

8,349

N/A

Net Income

$14.24M

+1908.9%

EBITDA

$34.87M

+127.0%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

$194.80M

+45.0%

Total Debt

$196.19M

-58.5%

Accounts Receivable

$122.92M

-12.4%

Inventory

$0.00

N/A

Long Term Debt

$148.82M

-65.0%

Short Term Debt

$47.37M

+0.1%

Return on Assets

1.08%

N/A

Return on Invested Capital

2.35%

N/A

Free Cash Flow

$22.34M

+317.8%

Operating Cash Flow

$33.11M

+1170.8%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
BKDBrookdale Senior Living Inc.
$15.37-0.65%
ACHCAcadia Healthcare Company, Inc.
$32.69+0.58%
CLOVClover Health Investments, Corp.
$4.34+1.52%
ADUSAddus HomeCare Corporation
$119.22+3.09%

Trending Stocks

Symbol / CompanyPricePrice Chg
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$5.22-0.01%
JBLUJetBlue Airways
$6.00+0.10%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$7.15-0.01%
FFord Motor Company
$14.96+0.02%

Questions About LFST

What is the current price of LifeStance Health Group?

LifeStance Health Group is trading at $11.24 per share.

What is the 52-week range for LifeStance Health Group?

Over the past 52 weeks, LifeStance Health Group has traded between $3.74 and $11.76.

How much debt does LifeStance Health Group have?

As of the most recent reporting period, LifeStance Health Group reported total debt of $476.77M.

How much cash does LifeStance Health Group have on hand?

LifeStance Health Group reported $194.80M in cash and cash equivalents in its most recent financial results.

What is LifeStance Health Group’s dividend yield?

LifeStance Health Group does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.